Amneal Pharmaceuticals (NYSE: AMRX) announced on Friday that it would be ramping up production of its malaria drug, hydroxychloroquine sulfate, for potential use in treating COVID-19 patient symptoms.
The Trump administration will use funds from the $2 trillion federal stimulus package to pay hospitals for treating uninsured coronavirus patients, Health and Human Services Secretary Alex Azar said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results